Spain detected a total of 59 cases of monkeypox on Wednesday and will order vaccines and antivirals through a group purchase of the European Union (EU), the government in Madrid announced, notes AFP.
A total of 59 positive cases were detected by the PCR test, 20 of which were confirmed by genomic sequencing, Health Minister Carolina Darias told a news conference.
“It is reasonable to assume that, being positive, all these people have the disease” of monkeypox, explained the director of the Carlos III Research Institute, Cristobal Belda, according to agerpres.ro.
Spain wants monkeypox to be vaccinated with EU-acquired vaccines after dozens of cases found
A total of 171 suspicious cases were detected in the country.
On the other hand, Spain intends to buy Imvanex and Tecovirimat antivirals through a group EU purchase to curb the spread of the virus, the health minister said.
The European Health Emergency Response Authority (HERA) “will make the vaccine available to Member States, in this case the Imvanex vaccine,” she said, without specifying the quantities or timing of distribution.
“HERA will set deadlines” and “doses will be distributed fairly among Member States” for these “limited production and limited access” products, the minister said.
Imvanex, from the Bavarian Nordic laboratory, is a 3rd generation vaccine authorized in Europe since 2013 and indicated against smallpox in adults.
There are no specific treatments or vaccines for smallpox in monkeys, but the multiplication of cases can be stopped by vaccination against smallpox, the WHO explained.
Smallpox has been detected in recent weeks in Europe and North America, a rare disease that originates in Africa and is usually cured spontaneously by humans.
Follow România Libera on Twitter, Facebook and Google News!